Course typologies, treatment principles, and research concepts

Pharmacopsychiatry

Volumn 37, Issue SUPPL. 2, 2004, Pages

  Gaebel, Wolfgang ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CONCEPT FORMATION; CONFERENCE PAPER; COPING BEHAVIOR; DISEASE COURSE; DISEASE MARKER; LONG TERM CARE; MENTAL STRESS; METHODOLOGY; MOOD DISORDER; NEUROBIOLOGY; NEUROSCIENCE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHIZOPHRENIA; SOCIAL PSYCHOLOGY; TREATMENT PLANNING; VALIDATION PROCESS;

BIOLOGICAL MARKERS; HUMANS; MOOD DISORDERS; PREDICTIVE VALUE OF TESTS; RESEARCH DESIGN; RISK FACTORS; SCHIZOPHRENIA; SOMATOTYPES;

EID: 9644265652     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-832661     Document Type: Conference Paper

References (49)

1. American Psychiatric Association. Practice guidelines for the treatment of patients with schizophrenia. Washington, DC: 1997
2. Awad AG. Prediction research of neuroleptic treatment outcome in schizophrenia - state of the art. In Gaebel W, Awad AG, editors. Prediction of neuroleptic treatment outcome in schizophrenia. Concepts and methods Wien: Springer, 1994: p 1-14
3. Berrios GE. The history of descriptive psychopathology. In Mezzich JE, Jorge MR, Salloum IM, editors. Psychiatric epidemiology. Assessment concepts and methods Baltimore: Hopkins University Press, 1994: p 47-68
4. Bleuler E. Dementia praecox oder Gruppe der Schizophrenien. In Aschaffenburg G, editor. Handbuch der Psychiatrie Leipzig: Deuticke, 1911
5. Bleuler M. The schizophrenic disorders: long-term patient and family studies. Translated by Clemens SM. New Haven, Conn: Yale University Press, 1978
6. Breier A, Schreiber JL, Dyer J, Pickar D. Course of illness and predictors of outcome in chronic schizophrenia: implications for pathophysiology. Br J Psychiatry 1992; (Suppl 18): 38-43
7. Detre T, McDonald MC. Managed care and the future of psychiatry. Arch Gen Psychiatry 1997; 54: 201-204
8. Engel GL. The clinical application of the biopsychosocial model. Am J Psychiatry 1980; 137: 535-544
9. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM. Conceptualization and rational for consensus definitions of terms in major depressive disorders. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48: 851-855
10. Gaebel W. Prediction research of outcome in neuroleptic treatment - definitions and concepts. In Gaebel W, Awad AG, editors. Prediction of neuroleptic treatment outcome in schizophrenia. Concepts and methods Wien: Springer, 1994: 15-26
11. Gaebel W. Illness theory and identity of psychiatry. Nervenarzt 2001; 72: 329-330
12. Gaebel W, Awad AG. Prediction of neuroleptic treatment outcome in schizophrenia. Wien: Springer, 1994
13. Gaebel W, Frommann N. Long-term course in schizophrenia: concepts, methods and research strategies. Acta Psychiatr Scand 2000; 102 (Suppl 407): 49-53
14. Gaebel W, Jänner M, Frommann N, Pietzcker A, Kopcke W, Linden M, Müller P, Müller-Spahn F, Tegeler J. First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies. Schizophr Res 2002; 53: 145-159
15. Gaebel W, Pietzker A, Ulrich G, Schley J, Müller-Oerlinghausen B. Predictors of neuroleptic treatment response in acute schizophrenia: results of a treatment study with perazine. Pharmacopsychiatry 1988; 21: 384-386
16. Goodman A. Organic unity theory: the mind-body problem revisited. Am J Psychiatry 1991; 148: 553-563
17. Gottesman II, McGuffin P, Farmer AE. Clinical genetics as clues to the genetics of schizophrenia. Schizophr Bull 1987; 13: 23-47
18. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 1994; 151: 1409-1416
19. Herz MI, Lamberti JS. Prodromal symptoms and relapse prevention in schizophrenia. Schizophr Bull 1995; 21: 541-551
20. Hogarty GE, Goldberg SC, Collaborative Study Group. Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates. Arch Gen Psychiatry 1973; 28: 54-64
21. Huber G, Gross G, Schüttler R. A long-term follow-up study of schizophrenia: psychiatric course of illness and prognosis. Acta Psychiatr Scand 1975; 52: 49-57
22. Kendler KS. A Psychiatric dialogue on the mind-body problem. Am J Psychiatry 2001; 158: 989-1000
23. Klein D. Harmful dysfunction, disorder, disease, illness and evolution. J Abnormal Psychol 1999; 108: 421-429
24. Kraemer HC, Kazdin AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ. Coming to terms with the terms of risk. Arch Gen Psychiatry 1997; 54: 337-343
25. Larsen TK, Friis S, Haahr U, Joa I, Johannessen JO, Melle I, Opjordsmoen S, Simonsen E, Vaglum P. Early detection and intervention in first-episode schizophrenia: a critical review. Acta Psychiatr Scand 2001; 103: 323-334
26. Lehman AF. Evaluating outcomes of treatments for persons with psychotic disorders. J Clin Psychiatry 1996; 57 (Suppl 11): 61-67
27. Lewis A. The state of psychiatry. New York: The science house, 1967
28. Lieberman JA, Kane JM, Sarantakos S, Gadaleta D, Woerner M, Alvir M, Ramos-Lorenzi J. Prediction of relapse in schizophrenia. Arch Gen Psychiatry 1987; 44: 597-603
29. Lieberman JA, Sheitman BB, Kinon BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacol 1997; 17: 205-229
30. Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J. The early stages of schizophrenia: Speculations on pathogenesis, pathophysiology, and therapeutic approaches. Society of Biological Psychiatry 2001; 50: 884-897
31. Lilienfeld S, Marino L. Mental disorder as a Roschian concept: a critique of Wakefield's "harmful dysfunction" analysis. J Abnormal Psy 1995; 104: 411-420
32. Linszen D, Dingemans P, Lenior M. Early intervention and a five year follow up in young adults with a short duration of untreated psychosis: ethical implications. Schizophr Res 2001; 51: 55-61
33. Marengo J. Classifying the courses of schizophrenia. Schizophr Bull 1994; 20: 519-536
34. May PRA. Predicting individual responses to drug treatment in schizophrenia: A test dose model. J Nerv Ment Dis 1976; 162: 177-183
35. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59: 921-928
36. Mrazek PJ, Haggarty RJ. Committee on prevention of mental disorders. Washington DC: National Academy Press, 1994
37. Nuechterlein KH. Vulnerability models for schizophrenia: State of the art. In Häfner HG, Janzarik W, editors. Search for the causes of schizophrenia Berlin: Springer, 1987: pp 297-316
38. Piaget J. The psychology of intelligence. In Piaget J, editor. The psychology of intelligence London: Routledge & Kegan Paul, 1992
39. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149: 999-1010
40. Riecher-Rossler A, Rossler W. The course of schizophrenic psychoses: what do we really know? A selective review from an epidemiological perspective. Eur Arch Psychiatry Clin Neurosci 1998; 248: 189-202
41. Strauss JS. Mediating processes in schizophrenia. Towards a new dynamic psychiatry. Br J Psychiatry 1989; 155: 22-28
42. Van Os J, Marcelis M. The ecogenetics of schizophrenia: a review. Schizophr Res 1998; 32: 127-135
43. Van Praag H. Over the mainstream: diagnostic requirements for biological psychiatric research. Psychiatry Res 1997; 72: 201-212
44. Van Praag H. Nosologomania: a disorder of psychiatry. World J Biol Psychiatry 2000; 1: 151-158
45. Wakefield J. Evolutionary versus prototype analyses of the concept of disorder. J Abnorm Psychol 1999; 108: 374-399
46. Warner R. The prevention of schizophrenia: what interventions are safe and effective? Schizophr Bull 2001; 27: 551-562
47. Watt DC, Katz K, Shepherd M. The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment. Psychol Med 1983; 13: 663-670
48. Wölwer W, Buchkremer G RN, Häfner H GW, Klosterkötter J, Maier W, Möller H-J, Gaebel W. German Research Network on Schizophrenia. Eur Arch Psychiatry Clin Neurosci 2003; 253: 321-329
49. Wyatt RJ, Damiani LM, Henter ID. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment. Br J Psychiatry 1998; 172 (Suppl): 77-83